Immune Checkpoint Inhibitor-Induced Upper Gastrointestinal Tract Inflammation Shows Morphologic Similarities to, but Is Immunologically Distinct From, Helicobacter pylori Gastritis and Celiac Disease

Immune checkpoint inhibitor (CPI) therapies are associated with multi-organ immune-related adverse events. Although colonic mucosal changes have been described, inflammatory changes incited by CPIs in the upper gastrointestinal tract have not been well characterized. To investigate morphologic and i...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Archives of pathology & laboratory medicine (1976) 2021-02, Vol.145 (2), p.191-200
Hauptverfasser:	Irshaid, Lina, Robert, Marie E, Zhang, Xuchen
Format:	Artikel
Sprache:	eng
Schlagworte:	Celiac disease Complications and side effects Development and progression Gastritis Immunotherapy Physiological aspects Receptor antibodies Risk factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!